Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$3.77 USD
-0.14 (-3.58%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.77 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/01/2024
Time: -- |
9/2024 | $-0.75 | -13.40% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.82 per share, missing the Zacks Consensus Estimate of -$0.69 per share. This reflects a negative earnings surprise of 18.84%. Look out for EDIT's next earnings release expected on November 01, 2024. For the next earning release, we expect the company to report earnings of -$0.75 per share, reflecting a year-over-year decrease of 36.36%.
Earnings History
Price & Consensus
Zacks News for EDIT
CRISPR (CRSP) Loses 24% YTD: How Should You Play the Stock?
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services